Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Rath, Timo ^a,b   Baker, Kristi ^a   Pyzik, Michal ^a   Blumberg, Richard S ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 12; OVALBUMIN; VIRUS GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTING CELL; ARTHRITIS; BIOAVAILABILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CITROBACTER RODENTIUM; COLITIS; DRUG DELIVERY SYSTEM; HELICOBACTER HEILMANNII; HELICOBACTER PYLORI; HEMATOPOIETIC CELL; HERPES SIMPLEX VIRUS 2; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSURVEILLANCE; LIVER PARENCHYMA; LUNG METASTASIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MUCOSAL IMMUNITY; MYASTHENIA GRAVIS; NONHUMAN; PASSIVE IMMUNIZATION; PEMPHIGUS VULGARIS; PROTEIN EXPRESSION; SHORT SURVEY; T LYMPHOCYTE; THROMBOCYTOPENIA; VACCINATION;

EID: 84919496171     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00664     Document Type: Short Survey

References (82)

1. Huber, A.H., Kelley, R.F., Gastinel, L.N. & Bjorkman, P.J. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J Mol Biol 230, 1077-1083 (1993).
2. Sanchez, L.M., Penny, D.M. & Bjorkman, P.J. Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand. Biochemistry 38, 9471-9476 (1999).
3. Schuck, P., Radu, C.G. & Ward, E.S. Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. Mol Immunol 36, 1117-1125 (1999).
4. Raghavan, M., Bonagura, V.R., Morrison, S.L. & Bjorkman, P.J. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34, 14649-14657 (1995).
5. Raghavan, M., Chen, M.Y., Gastinel, L.N. & Bjorkman, P.J. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity 1, 303-315 (1994).
6. Medesan, C., et al. Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site. Eur J Immunol 28, 2092-2100 (1998).
7. Medesan, C., Matesoi, D., Radu, C., Ghetie, V. & Ward, E.S. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol 158, 2211-2217 (1997).
8. Spiekermann, G.M., et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 196, 303-310 (2002).
9. Dickinson, B.L., et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest 104, 903-911 (1999).
10. Ober, R.J., Martinez, C., Vaccaro, C., Zhou, J. & Ward, E.S. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 172, 2021-2029 (2004).
11. Ward, E.S., et al. From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. Mol Biol Cell 16, 2028-2038 (2005).
12. Ward, E.S., Zhou, J., Ghetie, V. & Ober, R.J. Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans. Int Immunol 15, 187- 195 (2003).
13. Andersen, J.T. & Sandlie, I. The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug Metab Pharmacokinet 24, 318-332 (2009).
14. Baker, K., Rath, T., Pyzik, M. & Blumberg, R.S. The Role of FcRn in Antigen Presentation. Front Immunol 5, 408 (2014).
15. Rath, T., et al. Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol (2013).
16. Rath, T., et al. The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol 33 Suppl 1, S9-17 (2013).
17. Roopenian, D.C. & Akilesh, S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7, 715-725 (2007).
18. Akilesh, S., Christianson, G.J., Roopenian, D.C. & Shaw, A.S. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 179, 4580-4588 (2007).
19. Kobayashi, K., et al. An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. Gastroenterology 137, 1746-1756 e1741 (2009).
20. Montoyo, H.P., et al. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice. Proceedings of the National Academy of Sciences of the United States of America 106, 2788-2793 (2009).
21. Qiao, S.W., et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A 105, 9337-9342 (2008).
22. Baker, K., et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 31, 223-236 (2009).
23. Kuo, T.T., et al. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 30, 777-789 (2010).
24. Akilesh, S., et al. Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A 105, 967-972 (2008).
25. Antohe, F., Radulescu, L., Gafencu, A., Ghetie, V. & Simionescu, M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol 62, 93-105 (2001).
26. Bai, Y., et al. Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci U S A (2011).
27. Claypool, S.M., et al. Bidirectional transepithelial IgG transport by a strongly polarized basolateral membrane Fcgamma-receptor. Mol Biol Cell 15, 1746-1759 (2004).
28. Claypool, S.M., Dickinson, B.L., Yoshida, M., Lencer, W.I. & Blumberg, R.S. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J Biol Chem 277, 28038- 28050 (2002).
29. Ellinger, I., Rothe, A., Grill, M. & Fuchs, R. Apical to basolateral transcytosis and apical recycling of immunoglobulin G in trophoblast-derived BeWo cells: effects of low temperature, nocodazole, and cytochalasin D. Exp Cell Res 269, 322-331 (2001).
30. Ellinger, I., Schwab, M., Stefanescu, A., Hunziker, W. & Fuchs, R. IgG transport across trophoblast-derived BeWo cells: a model system to study IgG transport in the placenta. Eur J Immunol 29, 733-744 (1999).
31. Li, Z., et al. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A 108, 4388-4393 (2011).
32. Roopenian, D.C., et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 170, 3528-3533 (2003).
33. Yoshida, M., et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20, 769-783 (2004).
34. Belzer, C., Liu, Q., Carroll, M.C. & Bry, L. THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM. Eur J Microbiol Immunol (Bp) 1, 311-318 (2011).
35. Bry, L. & Brenner, M.B. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172, 433- 441 (2004).
36. Yoshida, M., et al. Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest 116, 2142-2151 (2006).
37. Ben Suleiman, Y., et al. Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice. Mucosal Immunol 5, 87- 98 (2012).
38. Montoyo, H.P., et al. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice. Proc Natl Acad Sci U S A 106, 2788-2793 (2009).
39. Baker, K., et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci U S A 108, 9927-9932 (2011).
40. Baker, K., et al. Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer. Immunity 39, 1095-1107 (2013).
41. Zhu, X., et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 166, 3266-3276 (2001).
42. Qiao, S.W., et al. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. Journal of immunology 175, 254-261 (2005).
43. Amigorena, S. & Savina, A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 22, 109-117 (2010).
44. Tao, M.H. & Morrison, S.L. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. Journal of immunology 143, 2595-2601 (1989).
45. Zalevsky, J., et al. Enhanced antibody half-life improves in vivo activity. Nat Biotechnol 28, 157-159 (2010).
46. Bitonti, A.J., et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci U S A 101, 9763-9768 (2004).
47. Israel, E.J., et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92, 69-74 (1997).
48. Dumont, J.A., et al. Delivery of an Erythropoietin-Fc Fusion Protein by Inhalation in Humans through an Immunoglobulin Transport Pathway. J Aerosol Med 18, 294-303 (2005).
49. Bitonti, A.J. & Dumont, J.A. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv Drug Deliv Rev 58, 1106-1118 (2006).
50. Low, S.C., Nunes, S.L., Bitonti, A.J. & Dumont, J.A. Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis. Hum Reprod 20, 1805-1813 (2005).
51. Vallee, S., et al. Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway. J Interferon Cytokine Res 32, 178-184 (2012).
52. Pridgen, E.M., et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med 5, 213ra167 (2013).
53. Grubb, J.H., et al. Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice. Proc Natl Acad Sci U S A 105, 8375-8380 (2008).
54. Chen, P., et al. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood (2010).
55. Li, C., et al. The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti- FcRn therapies. J Clin Invest 121, 4537-4547 (2011).
56. Maidji, E., McDonagh, S., Genbacev, O., Tabata, T. & Pereira, L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168, 1210-1226 (2006).
57. Ye, L., Zeng, R., Bai, Y., Roopenian, D.C. & Zhu, X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol 29, 158-163 (2011).
58. Lu, L., et al. A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection. J Virol 85, 10542- 10553 (2011).
59. Kacskovics, I., Cervenak, J., Erdei, A., Goldsby, R.A. & Butler, J.E. Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies. MAbs 3, 431-439 (2011).
60. Cong, Y., Feng, T., Fujihashi, K., Schoeb, T.R. & Elson, C.O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A 106, 19256-19261 (2009).
61. Leach, J.L., et al. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 157, 3317-3322 (1996).
62. Simister, N.E. & Story, C.M. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J Reprod Immunol 37, 1-23 (1997).
63. Simister, N.E., Story, C.M., Chen, H.L. & Hunt, J.S. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol 26, 1527-1531 (1996).
64. Dumont, J.A., et al. Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs. Blood 119, 3024-3030 (2012).
65. Mahlangu, J., et al. Phase 3 clinical study of recombinant Fc fusion factor VIII (rFVIIIFc) demonstrated safety, efficacy and improved pharmacokinetics (ALONG). Haemophilia 19, 70 (2013).
66. Mahlangu, J., et al. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood 123, 317-325 (2014).
67. Powell, J., et al. Safety, efficacy, and improved pharmacokinetics (PK) demonstrated in a phase 3 clinical trial of extended half life recombinant Fc fusion factor IX (B-LONG). Haemophilia 19, 76 (2013).
68. Powell, J.S., et al. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood 119, 3031-3037 (2012).
69. Powell, J.S., et al. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med 369, 2313-2323 (2013).
70. Shapiro, A.D., et al. Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood 119, 666-672 (2012).
71. Baker, K., Rath, T., Lencer, W.I., Fiebiger, E. & Blumberg, R.S. Crosspresentation of IgG-containing immune complexes. Cell Mol Life Sci (2012).
72. Akilesh, S., et al. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J Clin Invest 113, 1328-1333 (2004).
73. Hansen, R.J. & Balthasar, J.P. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. Thromb Haemost 88, 898-899 (2002).
74. Li, N., et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest 115, 3440-3450 (2005).
75. Liu, L., et al. Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade. J Immunol 178, 5390-5398 (2007).
76. Liu, Z., et al. Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med 186, 777-783 (1997).
77. Nimmerjahn, F. & Ravetch, J.V. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 204, 11-15 (2007).
78. Nimmerjahn, F. & Ravetch, J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26, 513-533 (2008).
79. Patel, D.A., et al. Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model. Journal of immunology 187, 1015-1022 (2011).
80. Petkova, S.B., et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18, 1759-1769 (2006).
81. Mezo, A.R., et al. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc Natl Acad Sci U S A 105, 2337- 2342 (2008).
82. Mezo, A.R., Sridhar, V., Badger, J., Sakorafas, P. & Nienaber, V. X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRn. J Biol Chem 285, 27694-27701 (2010).